- Previous Close
66.80 - Open
66.80 - Bid 63.40 x --
- Ask 64.40 x --
- Day's Range
63.40 - 67.00 - 52 Week Range
49.20 - 68.20 - Volume
19,715 - Avg. Volume
11,822 - Market Cap (intraday)
1.872B - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
72.36 - EPS (TTM)
0.89 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
www.eqlpharma.com22
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: EQL.ST
View MorePerformance Overview: EQL.ST
Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EQL.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EQL.ST
View MoreValuation Measures
Market Cap
1.94B
Enterprise Value
2.08B
Trailing P/E
75.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.68
Price/Book (mrq)
10.32
Enterprise Value/Revenue
7.15
Enterprise Value/EBITDA
51.85
Financial Highlights
Profitability and Income Statement
Profit Margin
9.04%
Return on Assets (ttm)
7.18%
Return on Equity (ttm)
15.04%
Revenue (ttm)
290.75M
Net Income Avi to Common (ttm)
26.29M
Diluted EPS (ttm)
0.89
Balance Sheet and Cash Flow
Total Cash (mrq)
13.37M
Total Debt/Equity (mrq)
74.66%
Levered Free Cash Flow (ttm)
-97.01M